Epigral Ltd — Quarterly Results & Earnings

₹839.00

-5.15%

Profit Growth YoY-36.02%Latest quarter

Sales Growth YoY-6.18%Latest quarter

Sales CAGR 5Y33.10%5 year compound

Profit CAGR 5Y25.81%5 year compound

📋

Quarterly Performance

YoY Profit Growth-36.02%

🔴 Significant decline

YoY Sales Growth-6.18%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

29.31%

EPS Growth 5Y

24.65%

Interest Coverage

Higher = safer debt servicing

9.11

ROE

22.30%

ROCE

24.88%

💡

Growth Analysis

Epigral Ltd reported YoY profit growth of -36.02% and revenue growth of -6.18% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 33.10% and profits at 25.81% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Epigral Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Specialty Chemicals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.